NCT02125877 - Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) | Biotech Hunter

Enrollment

173

Participants

Timeline

Start Date

July 8, 2014

Primary Completion Date

February 24, 2016

Study Completion Date

February 24, 2016

Conditions

Chronic Iron Overload Due to Transfusion-dependant Anemias

Interventions

DRUG

Deferasirox dispersible tablet

Deferasirox DT was provided as 125 mg, 250 mg and 500 mg dispersible tablets for oral use.

DRUG

Defearisox film-coated tablet

Deferasirox FCT was provided as 90 mg, 180 mg and 360 mg film-coated tablets for oral use.

Trial Locations (51)

1140

Novartis Investigative Site, Vienna

9115

Novartis Investigative Site, Dubai

10021

Weill Cornell Medical College-Cornell University Onc Dept, New York

10400

Novartis Investigative Site, Bangkok

10700

Novartis Investigative Site, Bangkok

10990

Novartis Investigative Site, Pulau Pinang

11472

Novartis Investigative Site, Riyadh

13353

Novartis Investigative Site, Berlin

14467

Novartis Investigative Site, Potsdam

15215

Novartis Investigative Site, Dammam

16128

Novartis Investigative Site, Genova

16132

Novartis Investigative Site, Genova

20122

Novartis Investigative Site, Milan

20162

Novartis Investigative Site, Milan

21589

Novartis Investigative Site, Jeddah

28033

Novartis Investigative Site, Madrid

30170

Novartis Investigative Site, Hanover

37126

Novartis Investigative Site, Verona

38642

Novartis Investigative Site, Goslar

40145

Novartis Investigative Site, Dammam

44100

Novartis Investigative Site, Cona

50589

Novartis Investigative Site, Kuala Lumpur

59020

Novartis Investigative Site, Lille

60611

Lurie Children's Hospital of Chicago Onc Dept, Chicago

68305

Novartis Investigative Site, Mannheim

72100

Novartis Investigative Site, Brindisi

73100

Novartis Investigative Site, Lecce

75010

Novartis Investigative Site, Paris

80138

Novartis Investigative Site, Napoli

89100

Novartis Investigative Site, Reggio Calabria

90127

Novartis Investigative Site, Palermo

90146

Novartis Investigative Site, Palermo

95125

Novartis Investigative Site, Catania

117198

Novartis Investigative Site, Moscow

92868-3874

Children's Hospital of Orange County Onc Dept, Orange

02115

Children's Hospital Boston Department of Hematology, Boston

19104-4399

Children's Hospital of Philadelphia Onc. Dept, Philadelphia

C1221ADC

Novartis Investigative Site, Buenos Aires

A-4010

Novartis Investigative Site, Linz

01307

Novartis Investigative Site, Dresden

04103

Novartis Investigative Site, Leipzig

GR-115 27

Novartis Investigative Site, Athens

265 04

Novartis Investigative Site, Patra - RIO

546 42

Novartis Investigative Site, Thessaloniki

09121

Novartis Investigative Site, Cagliari

PO Box 213

Novartis Investigative Site, Hazmiyeh

06726

Novartis Investigative Site, Mexico City

08041

Novartis Investigative Site, Barcelona

Unknown

Novartis Investigative Site, Al Ain - Abu Dhabi

N19 5NF

Novartis Investigative Site, London

NW1 2PJ

Novartis Investigative Site, London